NCT04484649

Brief Summary

This pilot study will: (1) develop Sleeping Healthy/Living Healthy, a school-based health center (SBHC) intervention that combines MBIH and sleep hygiene strategies to improve sleep quality in urban adolescents with poor sleep quality; (2) evaluate the feasibility and acceptability of intervention procedures; and (3) assess the preliminary intervention effects on sleep quality in urban adolescents. This study includes a development phase and a pilot individually-randomized group treatment (IRGT) phase. In Year 1, the investigators will develop the novel integrated intervention using an iterative participatory design process. In Year 2, the investigators will conduct an IRGT trial with 60 adolescents with insufficient sleep recruited from two SBHCs in New York City. Adolescents will be randomized 1:1 to receive the intervention or an attention control of equal intensity and duration. Process evaluation interviews guided by a rigorous fidelity framework with adolescents and with SBHC providers and personnel will be conducted to obtain feedback regarding intervention procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 23, 2020

Completed
1.2 years until next milestone

Study Start

First participant enrolled

October 12, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2022

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

September 20, 2024

Completed
Last Updated

September 20, 2024

Status Verified

May 1, 2024

Enrollment Period

8 months

First QC Date

July 21, 2020

Results QC Date

June 16, 2023

Last Update Submit

May 9, 2024

Conditions

Outcome Measures

Primary Outcomes (9)

  • Average Sleep Duration (Past 2 Weeks)

    Measured using actigraphy. Measured in minutes.

    Baseline (Day 0)

  • Average Sleep Duration (Past 2 Weeks)

    Measured with actigraphy. Measured in minutes.

    Immediate Post (up to 7 weeks after baseline)

  • Average Sleep Duration (Past 2 Weeks)

    Measured in actigraphy. Measured in minutes.

    Follow-up (up to 2.5 months)

  • Sleep Fragmentation - Sleep Efficiency (%) (Past Month)

    Represented as a percentage. Sleep efficiency = (# hours slept/# hours in bed) X 100% Sleep efficiency can range from 0-100%, with higher sleep efficiency representing better sleep. The numerator and denominator will be measured through actigraphy.

    Baseline (Day 0)

  • Sleep Fragmentation - Sleep Efficiency (%) (Past Month)

    Represented as a percentage. Sleep efficiency = (# hours slept/# hours in bed) X 100% Sleep efficiency can range from 0-100%, with higher sleep efficiency representing better sleep. The numerator and denominator will be measured through actigraphy.

    Immediate Post (up to 7 weeks after baseline)

  • Sleep Fragmentation - Sleep Efficiency (%) (Past Month)

    Represented as a percentage. Sleep efficiency = (# hours slept/# hours in bed) X 100% Sleep efficiency can range from 0-100%, with higher sleep efficiency representing better sleep. The numerator and denominator will be measured through actigraphy.

    Follow-up (up to 2.5 months)

  • Sleep Fragmentation - Number of Sleep Disruptions (Past Month)

    Number of sleep disruptions (number of times awakened) per night (mean, in past month): measured using actigraphy.

    Baseline (Day 0)

  • Sleep Fragmentation - Number of Sleep Disruptions (Past Month)

    Number of sleep disruptions (number of times awakened) per night (mean, in past month): measured using actigraphy.

    Immediate Post (up to 7 weeks after baseline)

  • Sleep Fragmentation - Number of Sleep Disruptions (Past Month)

    Number of sleep disruptions (number of times awakened) per night (mean, in past month): measured using actigraphy.

    Follow-up (up to 2.5 months)

Secondary Outcomes (18)

  • Score on Pittsburgh Sleep Quality Index (PSQI Global Score)

    Baseline (Day 0)

  • Score on Pittsburgh Sleep Quality Index (PSQI Global Score)

    Immediate Post (up to 7 weeks after baseline)

  • Score on Pittsburgh Sleep Quality Index (PSQI Global Score)

    Follow-up (up to 2.5 months)

  • Score on the Perceived Stress Scale (PSS)

    Baseline (Day 0)

  • Score on the Perceived Stress Scale (PSS)

    Immediate Post (up to 7 weeks after baseline)

  • +13 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Sleeping Healthy/Living Healthy

Behavioral: Sleeping Healthy/Living Healthy

Control

ACTIVE COMPARATOR

Attention Control

Behavioral: Attention Control

Interventions

Sleeping Healthy/Living Healthy will be a school based health center (SBHC)-based intervention integrating mind-body integrative health (MBIH) and sleep hygiene strategies to improve sleep quality in urban adolescents. The Sleeping Healthy/Living Healthy intervention content and format will be determined in a Development Phase 1. The investigator anticipates the intervention will consist of two group and two one-on-one sessions. The intervention will be grounded in social-cognitive theory and use motivational interviewing to support MBIH and sleep hygiene strategies. Sessions will be delivered once per week by SBHC providers and health educators.

Intervention

The Attention Control Intervention condition will meet the requirements for a comparison treatment for testing behavioral interventions - equivalent in contact time, credible and interesting, and exert limited treatment effects. In the same number of sessions and format as the Sleeping Healthy/Living Healthy intervention (anticipated to be two group and two one-on-one sessions delivered once per week by SBHC providers and health educators), the study will teach participants about sleep and other health topics relevant to adolescents (e.g., nutrition, injury prevention) devoid of the MBIH elements in our integrated intervention.

Control

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 13.0 -17.9;
  • Grade 9 - 11;
  • Currently enrolled as a patient in one of the participating SBHCs; and
  • Report sleep duration \< 8 hours (below the minimally recommended number of hours of sleep for this age group through the following questions: What time do you: a) usually fall asleep on weekdays and b) usually wake up on weekdays?).

You may not qualify if:

  • Report of prior diagnosis of a sleep disorder, such as sleep disordered breathing, restless leg syndrome, or periodic limb movement;
  • Significant developmental delay and/or severe psychiatric or medical conditions that preclude completion of study procedures or confound analyses; or
  • Not capable of communicating (reading, speaking, writing) in English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Stress, Psychological

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Results Point of Contact

Title
Samantha Garbers-Adams, PhD
Organization
Columbia University Irving Medical Center

Study Officials

  • Samantha Garbers-Adams, PhD

    Columbia University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2020

First Posted

July 23, 2020

Study Start

October 12, 2021

Primary Completion

June 7, 2022

Study Completion

June 7, 2022

Last Updated

September 20, 2024

Results First Posted

September 20, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations